63P Efficacy and safety results by menopausal status in monarchE: Adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2- high-risk early breast cancer

Authors :: S. Paluch-Shimon
P. Neven
J. Huober
I. Cicin
Z. Jiang
M.P. Goetz
C. Shimizu
C. Huang
R.J. Wei
S.C. Nabinger
T. Forrester
N. Harbeck
Source :: Annals of Oncology. 33:S151
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools